Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 11/20 | 1.00 |
| ▸ | TSHR | P16473 | 11/20 | 1.00 |
| ▸ | HPGD | P15428 | 8/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | CRHBP | P24387 | 1/20 | 0.50 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30375662 | 1.00 | HSD17B10 (1.00) | HSD17B10TSHRHPGDCYP3A4HSP90AA1 | |
| SCHEMBL27616586 | 0.97 | HSD17B10 (0.94) | HSD17B10TSHRHPGDCYP3A4HSP90AA1 | |
| Lithium SCHEMBL30477954 | 0.97 | HSD17B10 (0.94) | HSD17B10TSHRHPGDCYP3A4HSP90AA1 | |
| Water SCHEMBL31080947 | 0.97 | HSD17B10 (0.94) | HSD17B10TSHRHPGDCYP3A4HSP90AA1 | |
| SCHEMBL30477955 | 0.97 | HSD17B10 (0.94) | HSD17B10TSHRHPGDCYP3A4HSP90AA1 | |
| Pentachlorophenol SCHEMBL10591274 | 0.92 | HSD17B10 (0.84) | HSD17B10TSHRHPGDCYP3A4HSP90AA1 | |
| SCHEMBL1259609 | 0.83 | HSD17B10 (0.70) | HSD17B10TSHRHPGDCYP3A4HSP90AA1 | |
| SCHEMBL8644431 | 0.83 | HSD17B10 (0.71) | HSD17B10TSHRHPGDCYP3A4HSP90AA1 | |
| SCHEMBL23879337 | 0.82 | TSHR (0.71) | HSD17B10TSHRHPGDCYP3A4HSP90AA1 | |
| SCHEMBL6754079 | 0.81 | HSD17B10 (0.68) | HSD17B10TSHRHPGDCYP3A4HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1995 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678240-A2 | BRIDGE LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES | Hangzhou Dac Biotech Co., Ltd. (CN) | 2026-01-14 | — | — | EP | claimed |
| EP-3319936-B1 | BRIDGE LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES | HANGZHOU DAC BIOTECH CO LTD (CN) | 2025-12-17 | — | — | EP | claimed |
| US-12496351-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-12-16 | — | — | US | claimed |
| US-12472265-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-11-18 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| US-12433950-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-10-07 | — | — | US | claimed |
| EP-4621008-A1 | LIGHTWEIGHT MATERIAL, PREPARATION METHOD FOR AIR DEFLECTOR, AIR DEFLECTOR ASSEMBLY, AND AUTOMOBILE | Zhejiang Geely Holding Group Co., Ltd. (CN) | 2025-09-24 | — | — | EP | claimed |
| CN-120121751-A | Method for detecting chlorophenols in waste gas and application thereof | 华电莱州发电有限公司 | 2025-06-10 | — | — | CN | claimed |
| EP-0057153-A2 | Biocidal substances containing emulsifiable concentrates, aqueous emulsions obtained therefrom and utilization thereof for treating wood | XYLOCHIMIE (FR) | 1982-08-04 | — | — | EP | claimed |
| US-4294996-A | Method of reducing formation of chlorinated dioxins in manufacture of chlorinated phenols | REICHHOLD CHEMICALS, INCORPORATED (US) | 1981-10-13 | — | — | US | claimed |
| US-4288249-A | Water soluble pentachlorophenol and tetrachlorophenol wood treating systems | REICHHOLD CHEMICALS, INC. (US) | 1981-09-08 | — | — | US | claimed |
| US-4280012-A | DETOXIFICATION USING ACETYLENE OR HYDRAZINE | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1981-07-21 | — | — | US | claimed |
| US-4236973-A | BY PASSING A CURRENT OF VAPOR THROUGH A MOVING STREAM TO VAPORIZE ANY ORGANICS | THE DOW CHEMICAL COMPANY (US) | 1980-12-02 | — | — | US | claimed |
| US-4169049-A | USING BACTERIA BIOFILTER CONTAINING CONIFEROUS BARK TO DECOMPOSE CHLORINATED PHENOL POLLUTANTS | ENSO-GUTZEIT OSAKEYHTIO (FI) | 1979-09-25 | — | — | US | claimed |
| US-4103450-A | LOW DENSITY WEB IMPREGNATED WITH INSECTICIDE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-08-01 | — | — | US | claimed |
| US-3984417-A | Method of producing active amino acid esters | AJINOMOTO CO., INC. (JA) | 1976-10-05 | — | — | US | claimed |
| US-3971717-A | CHLOROPHENOL, DECOMPOSITION | GESELLSCHAFT FUR KERNFORSCHUNG M.B.H. (DT) | 1976-07-27 | — | — | US | claimed |
| US-3933783-A | Formation of peptide bonds in the presence of isonitriles | AJINOMOTO CO., INC. (JA) | 1976-01-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | FCGR2A, FCGR3B, FCGR1A | HSD17B10 2953/4885TSHR 1062/4885HPGD 3598/4885 |
| US-12433950-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | CD2BP2, DCLRE1A, EPCAM | HSD17B10 885/4885TSHR 3166/4885HPGD 2079/4885 |
| US-12496351-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | CD2BP2, DCLRE1A, EPCAM | HSD17B10 885/4885TSHR 3166/4885HPGD 2079/4885 |
| US-12472265-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | CD2BP2, DCLRE1A, EPCAM | HSD17B10 885/4885TSHR 3166/4885HPGD 2079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.